Bora Pharmaceuticals (US)
Baltimore, MD (Camden — fill/finish); Minneapolis, MN (OSD/generics) · United States
Key Differentiator
Taiwanese CDMO rapidly building US footprint through acquisitions
Core Services
Aseptic fill/finish (clinical & commercial, non-viral); Lyophilization; OSD manufacturing; Formulation development; Generics manufacturing & distribution
Capabilities
Market Intelligence
Taiwanese CDMO rapidly building US footprint through acquisitions. Beneficiary of Emergent BioSolutions facility divestitures. Unique Asian CDMO with growing North American presence.
Website
https://borapharma.comSimilar Companies
AGC Biologics
Bothell, WA (US HQ); Boulder, CO; Longmont, CO ·
Proprietary CHEF1® expression system
ARSI Canada Inc.
Mississauga, ON (Unit 16, 6800 Kitimat Rd) · Custom synthesis, analytical development, drug development
Mississauga CRO
Actylis (Montreal Operations)
Quebec ·
Global API and excipient supplier with Canadian manufacturing
Ajinomoto Bio-Pharma Services
San Diego, CA; Oss, Netherlands ·
Proprietary AJICAP™ site-specific ADC bioconjugation technology
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.